Abel Hall LLC
WST icon

Abel Hall LLC’s West Pharmaceutical WST Stock Holding History

Abel Hall LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$210K Sell
566
-1
-0.2% -$353 0.04% 670
2026
Q2 		$204K Buy
+567
New +$173K 0.04% 733

Other funds holding WST

ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Local Pensions Partnership Investment
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 16.58% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Abel Hall LLC's WST Position: Q3 2026 in Review

Abel Hall LLC reduced its West Pharmaceutical (WST) stake by 0.18% in Q3 2026, selling an estimated $353 and leaving 566 shares worth $210K. The position accounts for 0.04% of the portfolio, ranked #670.

Abel Hall LLC first reported a position in WST in Q2 2026 and has held it in 2 quarters since. 289 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Abel Hall LLC held 566 shares of West Pharmaceutical worth $210K as of Q3 2026.
  • Abel Hall LLC sold 1 West Pharmaceutical share in Q3 2026, an estimated $353.
  • West Pharmaceutical made up 0.04% of Abel Hall LLC's portfolio in Q3 2026, its #670 holding.
  • Abel Hall LLC first reported a position in West Pharmaceutical in Q2 2026 and has held it in 2 quarters since.
  • 289 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.